$XBI in the spotlight and trends to watch out for
When will markets rebound? And other questions...
There are early signs that private money in biotech is being accumulated but sitting on the sidelines waiting to be deployed. Q1 2023 was the 4th strongest quarter for new capital raised by venture funds in 6 years. There is growing interest from investors in jumping back into biopharma deals, at least in the private markets. However, there haven’t been…